The value of blood oxygenation level-dependent (BOLD) MR in differentiation of fumarate hydratase-deficient renal cell carcinoma and high-grade clear cell renal cell carcinoma

被引：0
|
作者：
Zhao, F. [1 ]
He, C. [2 ]
Chen, Y. [2 ]
Xu, H. [2 ]
Liu, H. [1 ]
Xu, N. [1 ]
Sun, G. [1 ]
Yao, J. [2 ]
Zeng, H. [1 ]
机构：
[1] Sichuan Univ, West China Sch Med, West China Hosp, Dept Urol, Chengdu, Peoples R China
[2] Sichuan Univ, West China Sch Med, West China Hosp, Dept Radiol, Chengdu, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.10.330
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
311P
引用
收藏
页码：S1523 / S1523
页数：1
相关论文
共 50 条
  • [31] Clinicopathologic Characteristics of Fumarate Hydratase-Deficient and Hereditary Leiomyomatosis and Renal Cell Carcinoma-Associated Renal Cell Carcinoma: A Series of 10 Cases
    Lau, Hubert
    Williamson, Sean R.
    Kunder, Christian
    Fan, Alice C.
    Kao, Chia-Sui
    MODERN PATHOLOGY, 2018, 31 : 358 - 358
  • [32] Clinicopathologic Characteristics of Fumarate Hydratase-Deficient and Hereditary Leiomyomatosis and Renal Cell Carcinoma-Associated Renal Cell Carcinoma: A Series of 10 Cases
    Lau, Hubert
    Williamson, Sean R.
    Kunder, Christian
    Fan, Alice C.
    Kao, Chia-Sui
    LABORATORY INVESTIGATION, 2018, 98 : 358 - 358
  • [33] Cytologic diagnosis of fumarate hydratase-deficient renal cell carcinoma: A single-institutional experience
    Mullane, Patrick C.
    Qian, Xiaohua
    Lau, Hubert D.
    Lowe, Alarice Cheng-Yi
    CANCER CYTOPATHOLOGY, 2025, 133 (02)
  • [34] Genomic Characteristics and Single-Cell Profiles After Immunotherapy in Fumarate Hydratase-Deficient Renal Cell Carcinoma
    Dong, Pei
    Zhang, Xinyue
    Peng, Yulu
    Zhang, Yijun
    Liu, Ruiqi
    Li, Yilin
    Pan, Qiwen
    Wei, Wensu
    Guo, Shengjie
    Zhang, Zhiling
    Han, Hui
    Zhou, Fangjian
    Liu, Yang
    He, Liru
    CLINICAL CANCER RESEARCH, 2022, 28 (21) : 4807 - 4819
  • [35] Advanced fumarate hydratase-deficient renal cell carcinoma responding to combination immune checkpoint inhibitors
    Howells, Erin
    Wigston, Lucas
    Mackie, Gavin
    Tran, Ben
    Nott, Louise
    CANADIAN JOURNAL OF UROLOGY, 2023, 30 (03)
  • [36] Fumarate Hydratase-Deficient Renal Cell Carcinoma-A Clinicopathological Study of a Series of 11 Cases
    Menon, Aswathy A.
    Rane, Swapnil
    Sakhadeo, Uma
    Prakash, Gagan
    Joshi, Amit
    Pal, Mahendra
    Arora, Amandeep
    Sable, Nilesh
    Katdare, Aparna
    Popat, Palak
    Maitre, Priyamvada
    Agarwal, Archi
    Murthy, Vedang
    Desai, Sangeetha B.
    Menon, Santosh
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2024, 45 (06) : 502 - 508
  • [37] Comprehensive Immunophenotypic Profiling of High Grade Renal Adenocarcinomas, including Renal Medullary Carcinoma (RMC), Collecting Duct Carcinoma (CDC), and Fumarate Hydratase-Deficient Renal Cell Carcinoma (FH-deficient RCC)
    Smith, Steven C.
    Mochel, Mark
    Amin, Mahul
    MODERN PATHOLOGY, 2018, 31 : 388 - 388
  • [38] Comprehensive Immunophenotypic Profiling of High Grade Renal Adenocarcinomas, including Renal Medullary Carcinoma (RMC), Collecting Duct Carcinoma (CDC), and Fumarate Hydratase-Deficient Renal Cell Carcinoma (FH-deficient RCC)
    Smith, Steven C.
    Mochel, Mark
    Amin, Mahul
    LABORATORY INVESTIGATION, 2018, 98 : 388 - 388
  • [39] The clinicopathologic and molecular features, and treatment outcome of fumarate hydratase-deficient renal cell carcinoma: a retrospective comparison with type 2 papillary renal cell carcinoma
    Bai, Junjie
    Li, Xiaoyan
    Wen, Yahui
    Lu, Qing
    Chen, Ru
    Liu, Rong
    Tong, Shangguan
    Ye, Yushi
    Lin, Jun
    Cai, Weizhong
    Kang, Deyong
    Chen, Jianhui
    AGING-US, 2024, 16 (04): : 3631 - 3646
  • [40] Asparagine stimulates growth and endoplasmic reticulum stress response in a fumarate hydratase-deficient renal cell carcinoma cell line
    Panarsky, Rony
    Yang, Youfeng
    Linehan, W. Marston
    Moscow, Jeffrey A.
    CANCER RESEARCH, 2018, 78 (13)
12345